Abstract
Retraction of ‘Aclarubicin regulates glioma cell growth and DNA damage through the SIRT1/PI3K/AKT signaling pathway’ by Jun-Feng Huo et al., RSC Adv., 2019, 9, 28775–28782, DOI: 10.1039/C9RA05572J.
Highlights
The images in the article, and the raw data provided by the authors, were screened by an image integrity expert
The raw data provided for all the western blots in the article was not genuine as it consisted of the bands being placed onto false backgrounds
The raw data provided by the authors cannot be used to validate the published data
Summary
Cite this: RSC Adv., 2021, 11, 5022 Retraction: Aclarubicin regulates glioma cell growth and DNA damage through the SIRT1/PI3K/ AKT signaling pathway
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
